Visgenx is developing therapeutics to protect against the loss of sight from retinal disorders. Our programs are based on increasing the expression of a gene known as ELOVL2 which may regulate aging in cells critical for vision.
View Top Employees from Visgenx, Inc| Website | http://www.visgenx.com |
| Revenue | $1 million |
| Employees | 9 (5 on RocketReach) |
| Founded | 2018 |
| Address | 3210 Merryfield Row, San Diego, California 92121, US |
| Phone | (408) 203-5023 |
| Technologies |
JavaScript,
HTML,
Twitter
+4 more
(view full list)
|
| Industry | Biotechnology Research, Consumer Services General, Biotechnology, Consumer Services, Therapeutic Devices |
| Competitors | Quiet Therapeutics |
| SIC | SIC Code 72 Companies, SIC Code 729 Companies |
| NAICS | NAICS Code 5619 Companies, NAICS Code 56199 Companies, NAICS Code 561990 Companies, NAICS Code 56 Companies, NAICS Code 561 Companies |
Looking for a particular Visgenx, Inc employee's phone or email?
Visgenx, Inc Questions
The Visgenx, Inc annual revenue was $1 million in 2024.
William Pedranti is the CEO of Visgenx, Inc.
5 people are employed at Visgenx, Inc.
Visgenx, Inc is based in San Diego, California.
The NAICS codes for Visgenx, Inc are [5619, 56199, 561990, 56, 561].
The SIC codes for Visgenx, Inc are [72, 729].
Top Visgenx, Inc Employees
-
5+5+
-
25+
-
15+
-
View
Christopher Chavez
Vice President of Research and Development at Visgenx, Inc
Santa Cruz, California, United States53 -
25+
Related Companies
